The monoclonal antibody developer, which counts GV and EMBL Ventures among its investors, had initially raised $40m when it floated last week.

Sun Pharmaceutical and Lundbeck scored exits in an $89.6m initial public offering by the subcutaneous heart failure therapy developer.

The EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.

The GV and EMBL Ventures-backed immunotherapy developer floated in an underpriced offering and received $20m in a private placement from NEA.

BitAuto's e-commerce and financing spinout, which counts Tencent, Baidu and JD.com as investors, floated at the top of its range.

Pennsylvania spinout Apellis Pharmaceuticals has floated on the Nasdaq Global Select Market after raising $150m in its initial public offering.

The China-based, SIG-backed online lender floated below its range in the US and is currently hovering just above the IPO price.

EMBL-backed Arsanis hopes to sell 3,125,000 shares priced at $15 to $17 and raise a total of up to $61m in its initial public offering.

The Tencent and Sohu-backed search engine operator will go public in the US today, floating at the top of its range.

The fabless semiconductor producer, which counts GlobalFoundries, Cisco, Intel, LSI and Xilinx as investors, has gone public in a $61.4m initial public offering.